116 related articles for article (PubMed ID: 32336198)
1. Platelet Reactivity in Individuals Over 65 Years Old Is Not Modulated by Age.
Chan MV; Chen MH; Barwari T; Huffman JE; Armstrong PC; Hwang SJ; Santer P; Wierer B; Mayr M; Kiechl S; Johnson AD; Willeit J; Warner TD
Circ Res; 2020 Jul; 127(3):394-396. PubMed ID: 32336198
[No Abstract] [Full Text] [Related]
2. Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease.
Wong S; Morel-Kopp MC; Chen Q; Appleberg M; Ward CM; Lewis DR
Thromb Haemost; 2006 Jun; 95(6):1042-3. PubMed ID: 16732389
[No Abstract] [Full Text] [Related]
3. [From platelet functions to therapy].
Jandrot-Perrus M; Nurden P
Rev Med Interne; 2010 Dec; 31 Suppl 3():S319-23. PubMed ID: 21056518
[No Abstract] [Full Text] [Related]
4. Platelet response to aspirin and clopidogrel in patients with peripheral atherosclerosis.
Madsen EH; Gehr NR; Johannesen NL; Schmidt EB; Kristensen SR
Platelets; 2011; 22(7):537-46. PubMed ID: 21591982
[TBL] [Abstract][Full Text] [Related]
5. High platelet reactivity on aspirin in patients with acute ST elevation myocardial infarction.
Dillinger JG; Saeed A; Spagnoli V; Sollier CB; Sideris G; Silberman SM; Voicu S; Drouet L; Henry P
Thromb Res; 2016 Aug; 144():56-61. PubMed ID: 27289074
[TBL] [Abstract][Full Text] [Related]
6. How much aspirin to inhibit platelet function?
Baker RI; Pitney WR
Med J Aust; 1982 Oct; 2(8):376-7. PubMed ID: 7144674
[No Abstract] [Full Text] [Related]
7. Platelet Reactivity in Patients on Aspirin and Clopidogrel Therapy Measured by a New Bedside Whole-Blood Assay.
Polzin A; Helten C; Dannenberg L; Mourikis P; Naguib D; Achilles A; Knoop B; Zako S; Rehder S; Görlinger K; Levkau B; Zeus T; Kelm M; Hohlfeld T; Hoffmann T
J Cardiovasc Pharmacol; 2019 Jan; 73(1):40-47. PubMed ID: 30383606
[TBL] [Abstract][Full Text] [Related]
8. The impact of renal function on platelet reactivity and clinical outcome in patients undergoing percutaneous coronary intervention with stenting.
Breet NJ; de Jong C; Bos WJ; van Werkum JW; Bouman HJ; Kelder JC; Bergmeijer TO; Zijlstra F; Hackeng CM; Ten Berg JM
Thromb Haemost; 2014 Dec; 112(6):1174-81. PubMed ID: 25231776
[TBL] [Abstract][Full Text] [Related]
9. Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease.
Larsen SB; Grove EL; Kristensen SD; Hvas AM
Thromb Haemost; 2013 May; 109(5):920-9. PubMed ID: 23407706
[TBL] [Abstract][Full Text] [Related]
10. Do the Behring Coagulation Timer and the Platelet Function Analyzer-100 identify the same patients as being aspirin non-responders?
Mortensen J; Poulsen TS; Refsgaard J; Kristensen SD
Platelets; 2007 Aug; 18(5):389-90; author reply 391-2. PubMed ID: 17654310
[No Abstract] [Full Text] [Related]
11. Proposal of a "gradient model" to evaluate residual platelet activity on antiplatelet therapy: A pilot study.
Lelli N; Rizkallah R; Ferrari P; Pedretti S; Cariani E; Trenti T
Thromb Res; 2017 Feb; 150():19-21. PubMed ID: 27992784
[No Abstract] [Full Text] [Related]
12. Genetic Variation in PEAR1, Cardiovascular Outcomes and Effects of Aspirin in a Healthy Elderly Population.
Lewis JP; Riaz M; Xie S; Polekhina G; Wolfe R; Nelson M; Tonkin AM; Reid CM; Murray AM; McNeil JJ; Shuldiner AR; Lacaze P
Clin Pharmacol Ther; 2020 Dec; 108(6):1289-1298. PubMed ID: 32562573
[TBL] [Abstract][Full Text] [Related]
13. Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions.
Hosokawa K; Ohnishi T; Sameshima H; Miura N; Ito T; Koide T; Maruyama I
Thromb Haemost; 2013 Jan; 109(1):102-11. PubMed ID: 23179055
[TBL] [Abstract][Full Text] [Related]
14. Reduced aspirin responsiveness as assessed by impedance aggregometry is not associated with adverse outcome after cardiac surgery in a small low-risk cohort.
Bolliger D; Filipovic M; Matt P; Tanaka KA; Gregor M; Zenklusen U; Seeberger MD; Lurati Buse G
Platelets; 2016; 27(3):254-61. PubMed ID: 26367099
[TBL] [Abstract][Full Text] [Related]
15. Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study.
Stuckey TD; Kirtane AJ; Brodie BR; Witzenbichler B; Litherland C; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Gurbel PA; Mehran R; Généreux P; Ben-Yehuda O; Simonton CA; Stone GW;
JACC Cardiovasc Interv; 2017 Aug; 10(16):1607-1617. PubMed ID: 28780034
[TBL] [Abstract][Full Text] [Related]
16. The influencing factors for clopidogrel-mediated platelet inhibition are assay-dependent.
Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
Thromb Res; 2011 Oct; 128(4):352-7. PubMed ID: 21621250
[TBL] [Abstract][Full Text] [Related]
17. Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment.
Temperilli F; Rina A; Massimi I; Montemari AL; Guarino ML; Zicari A; Pulcinelli FM
Platelets; 2015; 26(8):783-7. PubMed ID: 25734355
[TBL] [Abstract][Full Text] [Related]
18. Comparison between urinary 11-dehydrothromboxane B2 detection and platelet Light Transmission Aggregometry (LTA) assays for evaluating aspirin response in elderly patients with coronary artery disease.
Liu T; Zhang J; Chen X; Feng X; Fu SW; McCaffrey TA; Liu M
Gene; 2015 Oct; 571(1):23-7. PubMed ID: 26095809
[TBL] [Abstract][Full Text] [Related]
19. A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) study.
Mangiacapra F; Patti G; Barbato E; Peace AJ; Ricottini E; Vizzi V; Gatto L; D'Ambrosio A; De Bruyne B; Wijns W; Di Sciascio G
JACC Cardiovasc Interv; 2012 Mar; 5(3):281-9. PubMed ID: 22440493
[TBL] [Abstract][Full Text] [Related]
20. Adrenoreceptors, platelet reactivity and clopidogrel resistance.
Xiang YZ
Thromb Haemost; 2008 Nov; 100(5):729-30. PubMed ID: 18989508
[No Abstract] [Full Text] [Related]
[Next] [New Search]
